UNSPSC 85503209: Restriction of left temporal artery with extraluminal device, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to restriction of left temporal artery with extraluminal device, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 03VT4CZ

UNSPSC 85503209 Restriction of left temporal artery with extraluminal device, percutaneous endoscopic approach (Commodity) does not align with state and local procurement activity. The recent opportunities posted under this code span occupational health surveillance, pharmacy benefit management, temporary clinical staffing, independent medical evaluations for pension disability determinations, surgical procedure carve-outs for employee health plans, and emergency medical services for detained youth — none of which involve vascular intervention or endoscopic procedures on temporal arteries. The code appears to be a medical procedure classification that state and local procurement systems have misapplied to administrative health services, benefits management, and clinical staffing solicitations. The mismatch between the code's clinical specificity and the actual scope of work being purchased suggests either data-entry error or systematic miscoding in the source procurement platforms.

State and local buyers posting under this code include county human resources and benefits divisions (Collier County, City of Long Beach), state transportation departments (Washington State Department of Transportation), county health systems (County of Santa Clara, Harris County Juvenile Probation Department), and municipal retirement offices (City of Phoenix). No representative opportunities under this code involve the vascular procedure named in its title. Given the absence of genuine alignment, this code does not present a viable pursuit opportunity for firms in medical device, surgical services, or interventional vascular markets.